Effect of tapontadol and oxycodone in pain control

Phase 2

Recruiting

• Conditions: Patients with calculus of gallbladder candidated for laparoscopic cholecystectomy.; Calculus of gallbladder without cholecystitis; K80.2

• Registration Number: IRCT20190618043923N2
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients with cholelithiasis undergoing elective laparoscopic cholecystectomy
Physical status 1 or 2 according to the classification of the American Association of Anesthesiologists

Exclusion Criteria

Sensitivity to tapontadol or oxycodone
History of chronic consumption of other opioids or analgesics
Cardiac, liver, respiratory or renal disease
Surgeries for over one and a half hours
Complicated surgeries

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain intensity. Timepoint: Measuring the pain intensity at the beginning of the study (after surgery) and every two hours after the operation for up to 12 hours. Method of measurement: Visual analogue scale.;First request for pain medication. Timepoint: From the beginning of the study (after surgery) up to 12 hours after surgery. Method of measurement: Check patient records.;Amount of pain medication within 12 hours after surgery. Timepoint: From the beginning of the study (after surgery) up to 12 hours after surgery. Method of measurement: Check patient records.;Pain duration. Timepoint: From the beginning of the study (after surgery) up to 12 hours after surgery. Method of measurement: Self-declaration.